TNF and inflammatory bowel disease: A French population-based study found that inflammatory bowel disease (IBD) patients on TNF-alpha inhibitors had a lower rate of viral infections compared to patients on azathioprine (HR 0.57; 95% CI, 0.38–0.87) [84].